Intracranial Hemorrhage, Hypertensive Clinical Trial
Official title:
Neurological Outcomes of Primary Intracerebral Haemorrhage Admitted in Intensive Care Unit at the University Hospital of Grenoble Alpes
The main objective of this study is to determine the one-year neurological outcome of patients admitted to an intensive care unit (ICU) for a primary and spontaneous supratentorial intracerebral hemorrhages (ICH).
ICH represent a diagnostic and therapeutic emergency. ICH account for 20% of strokes with a
one-year mortality of more than 45% and an uncertain neurological outcome.
For ICH patients, the main initial challenge is to determine the long term neurological
outcomes and adapt the therapeutic strategy.
The majority of primary and spontaneous ICH studies involve patients in stroke units.
The study is an observational type 3 research with all the patients admitted in all the
University Hospital of Grenoble Alpes ICUs between July 2012 and July 2017 for a primary and
spontaneous supratentorial ICH
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03153150 -
Start or STop Anticoagulants Randomised Trial (SoSTART)
|
Phase 3 | |
Not yet recruiting |
NCT02782897 -
Intravenous Immunoglobulin for Acute Intracranial Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT06429657 -
Ketamine for Sedation in Severe Traumatic Brain Injury
|
Phase 4 | |
Completed |
NCT02811614 -
Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage
|
N/A | |
Completed |
NCT01689402 -
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
|
||
Recruiting |
NCT05778110 -
Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue
|